Isracann Biosciences Inc. (CSE: IPOT, OTC: ATLED, Forum) gave an operative overview and update regarding facility development activities in Israel on Monday. The Company had satisfied the escrow release conditions for the net proceeds of its $10.1 million (CAD) financing. IPOT is advancing its Phase One Facility Design and Construction Services Program at its greenhouse facility.
For more on this news, click here.
An Israeli cannabis Company focused on the European marketplace, Isracann Biosciences listed on the Canadian Securities Exchange earlier this month.
FULL DISCLOSURE: Isracann Biosciences Inc. is a client of Stockhouse Publishing.